The real-world efficacy of botulinum toxin type a (botox(R)) for the prophylaxis of headaches in adult patients with chronic migraine in australian clinical practice: a retrospective chart review

Conclusions In an Australian clinical practice review, almost three-quarters of CM patients obtained a meaningful reduction in headache days following two BOTOX treatments, fulfilling PBS continuation criterion. Additionally, the use of acute migraine medicines, including opioids, was reduced.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Tags: Abstracts Source Type: research